IDEXX Laboratories Earnings Estimate

IDXX Stock

USD 444.53 15.23 3.31%

The next projected EPS of IDEXX Laboratories is estimated to be 2.853 with future projections ranging from a low of 2.77 to a high of 2.96. IDEXX Laboratories' most recent 12-month trailing earnings per share (EPS TTM) is at 10.67. Please be aware that the consensus of earnings estimates for IDEXX Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

IDEXX Laboratories is projected to generate 2.853 in earnings per share on the 31st of March 2025. IDEXX Laboratories earnings estimates show analyst consensus about projected IDEXX Laboratories EPS (Earning Per Share). It derives the highest and the lowest estimates based on IDEXX Laboratories' historical volatility. Many public companies, such as IDEXX Laboratories, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

IDEXX Laboratories Revenue Breakdown by Earning Segment

By analyzing IDEXX Laboratories' earnings estimates, investors can diagnose different trends across IDEXX Laboratories' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, IDEXX Laboratories' Gross Profit is fairly stable compared to the past year. Pretax Profit Margin is likely to rise to 0.30 in 2025, whereas Gross Profit Margin is likely to drop 0.61 in 2025.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

IDEXX Laboratories Earnings Estimation Breakdown

The calculation of IDEXX Laboratories' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of IDEXX Laboratories is estimated to be 2.853 with the future projection ranging from a low of 2.77 to a high of 2.96. Please be aware that this consensus of annual earnings estimates for IDEXX Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.

Last Reported EPS

2.62

2.77

Lowest

Expected EPS

2.853

2.96

Highest

IDEXX Laboratories Earnings Projection Consensus

Suppose the current estimates of IDEXX Laboratories' value are higher than the current market price of the IDEXX Laboratories stock. In this case, investors may conclude that IDEXX Laboratories is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and IDEXX Laboratories' stock will quickly adjusts to the new information provided by the consensus estimate.

Number of Analysts	Historical Accuracy	Last Reported EPS		Estimated EPS for 31st of March 2025	Current EPS (TTM)
14	94.51%	2.62		2.853	10.67

IDEXX Laboratories Earnings History

Earnings estimate consensus by IDEXX Laboratories analysts from Wall Street is used by the market to judge IDEXX Laboratories' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only IDEXX Laboratories' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

IDEXX Laboratories Quarterly Gross Profit

570.66 Million

At this time, IDEXX Laboratories' Retained Earnings are fairly stable compared to the past year. Retained Earnings Total Equity is likely to rise to about 4.3 B in 2025, whereas Price Earnings Ratio is likely to drop 23.63 in 2025. Common Stock Shares Outstanding is likely to rise to about 94.1 M in 2025. Net Income Applicable To Common Shares is likely to rise to about 820 M in 2025.

Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of IDEXX Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

Hype

Prediction

Low	Estimated	High
442.53	444.60	446.67

Details

Intrinsic

Valuation

Low	Real	High
400.08	457.13	459.20

Details

Naive

Forecast

Low	Next	High
434.77	436.84	438.90

Details

14 Analysts

Consensus

Low	Target	High
435.55	478.62	531.27

Details

Note that many institutional investors and large investment bankers can move markets due to the volume of IDEXX assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards IDEXX Laboratories. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving IDEXX Laboratories' stock price in the short term.

IDEXX Laboratories Earnings per Share Projection vs Actual

Actual Earning per Share of IDEXX Laboratories refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering IDEXX Laboratories predict the company's earnings will be in the future. The higher the earnings per share of IDEXX Laboratories, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

IDEXX Laboratories Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as IDEXX Laboratories, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of IDEXX Laboratories should always be considered in relation to other companies to make a more educated investment decision.

IDEXX Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact IDEXX Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2025-02-03	2024-12-31	2.3989	2.62	0.2211	9
2024-10-31	2024-09-30	2.68	2.8	0.12	4
2024-08-06	2024-06-30	2.88	3.02	0.14	4
2024-05-01	2024-03-31	2.67	2.81	0.14	5
2024-02-05	2023-12-31	2.12	2.32	0.2	9
2023-11-01	2023-09-30	2.37	2.53	0.16	6
2023-08-01	2023-06-30	2.47	2.67	0.2	8
2023-05-02	2023-03-31	2.42	2.55	0.13	5
2023-02-06	2022-12-31	1.94	2.05	0.11	5
2022-11-01	2022-09-30	2.04	2.15	0.11	5
2022-08-02	2022-06-30	1.56	1.56	0.0	0
2022-05-04	2022-03-31	2.26	2.27	0.01	0
2022-02-02	2021-12-31	1.71	1.89	0.18	10
2021-11-02	2021-09-30	1.91	2.03	0.12	6
2021-07-30	2021-06-30	2.02	2.34	0.32	15
2021-05-04	2021-03-31	1.72	2.35	0.63	36
2021-02-02	2020-12-31	1.4	2.01	0.61	43
2020-10-29	2020-09-30	1.43	1.69	0.26	18
2020-07-31	2020-06-30	1.17	1.72	0.55	47
2020-04-30	2020-03-31	1.2	1.29	0.09	7
2020-01-31	2019-12-31	0.9	1.04	0.14	15
2019-10-31	2019-09-30	1.14	1.24	0.1	8
2019-08-01	2019-06-30	1.37	1.43	0.06	4
2019-05-01	2019-03-31	1.05	1.17	0.12	11
2019-02-01	2018-12-31	0.9	0.98	0.08	8
2018-11-01	2018-09-30	0.97	1.05	0.08	8
2018-08-01	2018-06-30	1.17	1.23	0.06	5
2018-05-04	2018-03-31	0.92	1.01	0.09	9
2018-02-01	2017-12-31	0.73	0.77	0.04	5
2017-10-31	2017-09-30	0.74	0.79	0.05	6
2017-08-01	2017-06-30	0.85	0.95	0.1	11
2017-04-28	2017-03-31	0.61	0.77	0.16	26
2017-02-02	2016-12-31	0.51	0.58	0.07	13
2016-11-01	2016-09-30	0.6	0.62	0.02	3
2016-08-02	2016-06-30	0.62	0.74	0.12	19
2016-04-29	2016-03-31	0.47	0.51	0.04	8
2016-01-29	2015-12-31	0.44	0.48	0.04	9
2015-10-28	2015-09-30	0.53	0.54	0.01	1
2015-07-30	2015-06-30	0.57	0.6	0.03	5
2015-04-28	2015-03-31	0.49	0.49	0.0	0
2015-01-30	2014-12-31	0.4	0.48	0.08	20
2014-10-24	2014-09-30	0.45	0.53	0.08	17
2014-07-25	2014-06-30	0.53	0.55	0.02	3
2014-04-25	2014-03-31	0.43	0.45	0.02	4
2014-02-04	2013-12-31	0.4	0.41	0.01	2
2013-10-22	2013-09-30	0.41	0.43	0.02	4
2013-07-23	2013-06-30	0.48	0.5	0.02	4
2013-04-23	2013-03-31	0.41	0.41	0.0	0
2013-01-29	2012-12-31	0.35	0.37	0.02	5
2012-10-19	2012-09-30	0.36	0.38	0.02	5
2012-07-20	2012-06-30	0.45	0.46	0.01	2
2012-04-20	2012-03-31	0.35	0.36	0.01	2
2012-01-27	2011-12-31	0.31	0.31	0.0	0
2011-10-21	2011-09-30	0.32	0.33	0.01	3
2011-07-22	2011-06-30	0.36	0.42	0.06	16
2011-04-21	2011-03-31	0.3	0.31	0.01	3
2011-01-28	2010-12-31	0.27	0.31	0.04	14
2010-10-22	2010-09-30	0.27	0.3	0.03	11
2010-07-23	2010-06-30	0.31	0.31	0.0	0
2010-04-23	2010-03-31	0.25	0.28	0.03	12
2010-01-29	2009-12-31	0.23	0.26	0.03	13
2009-10-23	2009-09-30	0.22	0.26	0.04	18
2009-07-24	2009-06-30	0.26	0.28	0.02	7
2009-04-24	2009-03-31	0.19	0.22	0.03	15
2009-01-30	2008-12-31	0.21	0.22	0.01	4
2008-10-24	2008-09-30	0.2	0.21	0.01	5
2008-07-25	2008-06-30	0.28	0.32	0.04	14
2008-04-25	2008-03-31	0.2	0.21	0.01	5
2008-01-25	2007-12-31	0.2	0.2	0.0	0
2007-10-26	2007-09-30	0.2	0.2	0.0	0
2007-07-27	2007-06-30	0.21	0.22	0.01	4
2007-04-27	2007-03-31	0.15	0.16	0.01	6
2007-01-26	2006-12-31	0.15	0.19	0.04	26
2006-10-27	2006-09-30	0.17	0.19	0.02	11
2006-07-28	2006-06-30	0.16	0.2	0.04	25
2006-04-28	2006-03-31	0.14	0.14	0.0	0
2006-01-27	2005-12-31	0.15	0.16	0.01	6
2005-10-28	2005-09-30	0.15	0.16	0.01	6
2005-07-29	2005-06-30	0.14	0.15	0.01	7
2005-04-29	2005-03-31	0.12	0.13	0.01	8
2005-01-28	2004-12-31	0.12	0.12	0.0	0
2004-10-22	2004-09-30	0.12	0.14	0.02	16
2004-07-23	2004-06-30	0.13	0.14	0.01	7
2004-04-19	2004-03-31	0.12	0.12	0.0	0
2004-01-26	2003-12-31	0.1	0.12	0.02	20
2003-10-20	2003-09-30	0.1	0.11	0.01	10
2003-07-21	2003-06-30	0.11	0.12	0.01	9
2003-04-21	2003-03-31	0.08	0.09	0.01	12
2003-01-27	2002-12-31	0.09	0.09	0.0	0
2002-10-21	2002-09-30	0.09	0.09	0.0	0
2002-07-15	2002-06-30	0.08	0.09	0.01	12
2002-04-12	2002-03-31	0.06	0.07	0.01	16
2002-01-25	2001-12-31	0.07	0.07	0.0	0
2001-10-15	2001-09-30	0.07	0.08	0.01	14
2001-07-17	2001-06-30	0.07	0.07	0.0	0
2001-04-12	2001-03-31	0.06	0.06	0.0	0
2001-01-25	2000-12-31	0.07	0.07	0.0	0
2000-10-13	2000-09-30	0.07	0.07	0.0	0
2000-07-18	2000-06-30	0.07	0.07	0.0	0
2000-04-14	2000-03-31	0.05	0.06	0.01	20
2000-01-28	1999-12-31	0.06	0.06	0.0	0
1999-10-15	1999-09-30	0.05	0.05	0.0	0
1999-07-16	1999-06-30	0.05	0.05	0.0	0
1999-04-16	1999-03-31	0.05	0.05	0.0	0
1999-02-05	1998-12-31	0.04	0.04	0.0	0
1998-10-16	1998-09-30	0.04	0.04	0.0	0
1998-07-17	1998-06-30	0.04	0.03	-0.01	25
1998-04-17	1998-03-31	0.03	0.03	0.0	0
1998-02-12	1997-12-31	0.02	0.02	0.0	0
1997-10-17	1997-09-30	0.01	0.02	0.01	100
1997-07-18	1997-06-30	-0.01	-0.01	0.0	0
1997-04-18	1997-03-31	0.01	0.01	0.0	0
1997-02-14	1996-12-31	0.06	0.06	0.0	0
1996-10-18	1996-09-30	0.05	0.06	0.01	20
1996-07-19	1996-06-30	0.05	0.05	0.0	0
1996-04-19	1996-03-31	0.05	0.05	0.0	0

About IDEXX Laboratories Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of IDEXX Laboratories earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current IDEXX Laboratories estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as IDEXX Laboratories fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'

Please read more on our stock advisor page.

	Last Reported	Projected for Next Year
Retained Earnings	5.1 B	5.4 B
Retained Earnings Total Equity	4.1 B	4.3 B
Earnings Yield	0.03	0.03
Price Earnings Ratio	38.33	23.63
Price Earnings To Growth Ratio	6.29	6.60

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

IDEXX Laboratories Earnings Estimate

IDEXX Laboratories Revenue Breakdown by Earning Segment

IDEXX Laboratories Earnings Estimation Breakdown

IDEXX Laboratories Earnings Projection Consensus

IDEXX Laboratories Earnings History

IDEXX Laboratories Quarterly Gross Profit

570.66 Million

IDEXX Laboratories Earnings per Share Projection vs Actual

IDEXX Laboratories Estimated Months Earnings per Share

IDEXX Quarterly Analyst Estimates and Surprise Metrics

About IDEXX Laboratories Earnings Estimate

Also Currently Popular

Additional Tools for IDEXX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY